AbbVie
ABBV
1,286 hedge funds and large institutions have $44.6B invested in AbbVie in 2013 Q2 according to their latest regulatory filings, with 1,286 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
68.14% more ownership
Funds ownership: 0% → 68.14% (+68%)
33% more call options, than puts
Call options by funds: $182M | Put options by funds: $137M
Top Buyers
Top Sellers
ABBV Hedge Fund Activity: Q2 2013 in Review
1,286 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2013, worth a combined $44.6B.
Buyers outnumbered sellers: 1,286 funds opened new ABBV positions and 0 closed out — a net gain of 1,286 holders — while 0 added to existing stakes and 0 trimmed.
- 1,286 institutional investors held AbbVie (ABBV) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $44.6B of AbbVie stock for Q2 2013.
- 1,286 funds opened new AbbVie positions in Q2 2013 and 0 closed out, a net change of +1,286 holders.
Based on aggregated 13F filings for Q2 2013.